Regeneron Pharma Split history
Regeneron Pharma has not split the face value of the share since Jan 1, 2000.
See all forthcoming SplitsDividend history for Regeneron Pharma
Regeneron Pharma has declared 6 dividends since Feb. 20, 2025.
In the past 12 months, Regeneron Pharma has declared an equity dividend amounting to $3.58 per share.
At the current share price of $709.2100, Regeneron Pharma's dividend yield is 0.50%. Adjusting for Split the dividend yield is 0.12%.
| Ex-Date | Dividend Amount | Instrument Type |
|---|---|---|
| 20 May 2026 | 0.94 | Equity Share |
| 20 Feb 2026 | 0.94 | Equity Share |
| 20 Nov 2025 | 0.88 | Equity Share |
| 18 Aug 2025 | 0.88 | Equity Share |
| 20 May 2025 | 0.88 | Equity Share |
| 20 Feb 2025 | 0.88 | Equity Share |
Board Meetings - Regeneron Pharma
The next board meeting for Regeneron Pharma is on 12 May 2026 for the purpose of BofA Securities Health Care Conference 2026
| Ex-Date | Purpose | Notes |
|---|---|---|
| 31 Jul 2026 | Regeneron Pharmaceuticals Inc Second Quarter Earnings Results for 2026 | - |
| 31 Jul 2026 | Regeneron Pharmaceuticals Inc Second Quarter Earnings Conference Call for 2026 | - |
| 12 Jun 2026 | Regeneron Pharmaceuticals Inc Annual General Meeting for 2026 | - |
| 08 Jun 2026 | Goldman Sachs 47th Annual Global Healthcare Conference | - |
| 12 May 2026 | BofA Securities Health Care Conference 2026 | - |
| 29 Apr 2026 | Regeneron Pharmaceuticals Inc First Quarter Earnings Conference Call for 2026 | - |
| 29 Apr 2026 | Regeneron Pharmaceuticals Inc First Quarter Earnings Result for 2026 | - |
| 22 Apr 2026 | Regeneron Roundtable: gMG & C5 Complement Program | - |
| 11 Mar 2026 | Leerink Partners 2026 Global Healthcare Conference | - |
| 10 Mar 2026 | Barclays 28th Annual Global Healthcare Conference | - |